Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMCI vs GSK✓SelectedUSD · GSKSMCI vs GSK performance historyLatest closeAs of+0.95%11/18
Stock and ETF performance explorer

SMCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,682.0%
GSK return
+136.2%
Excess return
+2,545.7%
Maximum drawdown
-84.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-1.3%+2.3%+1.7%
7D-19.9%-3.1%-16.8%-18.6%
30D-24.1%-0.9%-23.2%-24.2%
3M-34.9%-4.2%-30.7%-34.3%
6M-21.0%-1.6%-19.4%-22.7%
YTD-16.7%+2.6%-19.3%-20.3%
1Y-30.2%+6.2%-36.4%-34.6%
3Y-15.6%+55.0%-70.5%-39.3%
5Y+468.6%+42.8%+425.8%+312.5%
10Y+839.1%+102.1%+737.0%+424.4%
All+2,682.0%+136.2%+2,545.7%+1,144.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling